中国神经再生研究(英文版) ›› 2019, Vol. 14 ›› Issue (5): 850-857.doi: 10.4103/1673-5374.249233

• 原著:脑损伤修复保护与再生 • 上一篇    下一篇

经颈静脉肝内门静脉分流肝髓样病变患者局部脑结构异常:基于体素的形态测定

  

  • 出版日期:2019-05-15 发布日期:2019-05-15

Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study

Kang Liu 1 , Gang Chen 2 , Shu-Yao Ren 3 , Yuan-Qiang Zhu 4 , Tian-Lei Yu 3 , Ping Tian 1 , Chen Li 1 , Yi-Bin Xi 1 , Zheng-Yu Wang 3 , Jian-Jun Ye 2 , Guo-Hong Han 3 , Hong Yin 1   

  1. 1 Department of Radiology, Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), Xi’an, Shaanxi Province, China
    2 Department of Radiology, Lanzhou General Hospital, Lanzhou Military Command, Lanzhou, Gansu Province, China
    3 Xijing Hospital of Digestive Diseases, Air Force Military Medical University (Fourth Military Medical University), Xi’an, Shaanxi Province, China
    4 Life Sciences Research Center, School of Life Sciences and Technology, Xidian University, Xi’an, Shaanxi Province, China
  • Online:2019-05-15 Published:2019-05-15
  • Contact: Hong Yin, MD, fmmu_yin@163.com.

摘要:

肝性脊髓病是慢性肝衰竭患者的一种并发症,与门体分流关系密切,其主要症状为下肢进行性运动障碍。作为运动中枢的大脑在肝性脊髓病下肢运动障碍中扮演怎样的角色目前尚知之甚少。试验将探讨继发于经颈内静脉肝内门体分流术后肝性脊髓病患者脑灰质的改变及其临床意义。试验于2014年3月至2016年11月在第四军医大学西京医院募集经颈内静脉肝内门体分流术后罹患肝性脊髓病的患者(肝性脊髓病组)23例、经颈内静脉肝内门体分流术后未患肝性脊髓病的患者(非肝性脊髓病组)23例以及23例人口学资料匹配的健康对照者。采集受试者的脑高分辨率磁共振结构像,使用基于体素的形态测量分析来评估脑灰质的组间差异,然后通过相关分析来研究异常脑灰质和运动特征之间的关系发现:(1)与非肝性脊髓病组相比,肝性脊髓病组左侧岛叶、丘脑、额上回、右侧中扣带回灰质体积减小,右侧尾状核灰质体积增大(P < 0.05,AlphaSim校正);(2)肝性脊髓病组右尾状核灰质体积与Fugl-Meyer下肢运动评分呈负相关(r = -0.53,P = 0.01);(3)与健康对照组相比,肝性脊髓病和非肝性脊髓病患者双侧丘脑灰质体积增大,双侧壳核、苍白球、小脑半球及小脑蚓部灰质体积减小;(4)上述数据说明,该研究揭示了肝性脊髓病患者脑灰质结构的异常变化,运动相关脑区受累明显,这可能与其运动功能障碍有关。右侧尾状核体积增大有助于预测经颈内静脉肝内门体分流术后肝性脊髓病患者下肢运动功能减弱。此试验已经过第四军医大学西京医院伦理委员会批准(批准号:20140227-6),参加者均知情同意。

orcid: 0000-0001-8830-5826 (Hong Yin)

关键词: 门体分流, 肝性脊髓病, 肝性脑病, 磁共振, 灰质, 下肢, Fugl-Meyer运动评分, 基底节, 尾状核, 基于体素的形态测量

Abstract:

Hepatic myelopathy is a complication seen in patients with chronic liver failure with physiologic or iatrogenic portosystemic shunting. The main symptom is progressive lower limb dyskinesia. The role of the brain motor control center in hepatic myelopathy is unknown. This study aimed to investigate the gray matter changes in patients with hepatic myelopathy secondary to transjugular intrahepatic por-tosystemic shunt and to examine their clinical relevance. This was a cross-sectional study. Twenty-three liver failure patients with hepatic myelopathy (hepatic myelopathy group), 23 liver failure patients without hepatic myelopathy (non-hepatic myelopathy group) after transjugular intrahepatic portosystemic shunt, and 23 demographically matched healthy volunteers were enrolled from March 2014 to November 2016 at Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China. High-resolution magnetization-prepared rapid gradient-echo brain imaging was acquired. Group differences in regional gray matter were assessed using voxel-based morphometry analysis. The relationship between aberrant gray matter and motor characteristics was investigated. Results demonstrated that compared with the non-hepatic myelopathy group, gray matter volume abnormalities were asymmetric, with decreased volume in the left insula (P = 0.003), left thalamus (P = 0.029), left superior frontal gyrus (P = 0.006), and right middle cingulate cortex (P = 0.021), and increased volume in the right caudate nucleus (P = 0.017), corrected with open-source software. The volume of the right caudate nucleus in the hepatic myelopathy group negatively correlated with the lower limb clinical rating of the Fugl-Meyer Assessment (r = –0.53, P = 0.01). Compared with healthy controls, patients with and without hepatic myelopathy exhibited overall increased gray matter volume in both thalami, and decreased gray matter volume in both putamen, as well as in the globus pallidus, cerebellum, and vermis. The gray matter abnormalities we found predominantly involved motor-related regions, and may be associated with motor dysfunction. An enlarged right caudate nucleus might help to predict weak lower limb motor performance in patients with preclinical hepatic myelopathy after transjugular intrahepatic portosystemic shunt. This study was approved by the Ethics Committee of Xijing Hospital, Air Force Mili¬tary Medical University (Fourth Military Medical University), China (approval No. 20140227-6) on February 27, 2014.

Key words: portosystemic shunt, hepatic myelopathy, hepatic encephalopathy, magnetic resonance imaging, gray matter, lower limb, Fugl-Meyer Assessment, basal ganglia, caudate nucleus, voxel-based morphometry